SOX9 was found to be overexpressed in osteosarcoma that were high grade, metastatic, recurrent, or showed a poor response to therapy, suggesting that it may serve as a marker for osteosarcoma [16]. This evidence concerns the gene SOX9 and osteosarcoma.